Why does chronic heart failure cause breathlessness and fatigue?

Progress in Cardiovascular Diseases

Volumn 49, Issue 5, 2007, Pages 366-384

  Witte, Klaus K ^a   Clark, Andrew L ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANEMIA; ARTICLE; CHEMORECEPTOR; DYSPNEA; EXERCISE; FATIGUE; GAS EXCHANGE; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HEMODYNAMICS; HUMAN; LUNG CIRCULATION; LUNG EDEMA; LUNG FUNCTION; LUNG VENTILATION PERFUSION RATIO; MUSCLE BLOOD FLOW; SKELETAL MUSCLE; SYMPTOMATOLOGY;

DYSPNEA; EXERCISE TEST; FATIGUE; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 33847103071     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2006.10.003     Document Type: Article

References (200)

1. Harrington D., Anker S.D., and Coats A.J. Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J 22 (2001) 392-399
2. Brown Jr. C.C., Fry D.L., and Ebert R.V. The mechanisms of pulmonary ventilation in patients with heart disease. Am J Med 17 (1954) 438-446
3. Witte K.K.A., Nikitin N.P., Cleland J.G.F., et al. Exercise tolerance and tissue Doppler imaging in chronic heart failure. Heart 90 (2004) 1144-1150
4. Clark A.L., Sparrow J.L., and Coats A.J. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin?. Eur Heart J 16 (1995) 49-52
5. Lipkin D.P., Canepa-Anson R., Stephens M.R., et al. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J 55 (1986) 439-445
6. Fink L.I., Wilson J.R., and Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 57 (1986) 249-253
7. Witte K.K.A., and Clark A.L. Cycle exercise causes a lower ventilatory response to exercise in chronic heart failure. Heart 91 (2005) 225-226
8. The Criteria Committee of the New York Heart Association. Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis. ed 7 (1973), Little, Brown and Co, Boston 286
9. Scrutinio D., Lagioia R., Ricci A., et al. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 15 (1994) 1089-1095
10. Smith R.F., Johnson G., Ziesche S., et al. Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 6 Suppl (1993) VI88-VI93
11. Borg G. Subjective effort and physical activities. Scand J Rehabil 6 (1978) 108-113
12. Ingle L., Shelton R.J., Rigby A.S., et al. The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J 26 (2005) 1742-1751
13. Francis D.P., Shamim W., Davies L.C., et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 21 (2000) 154-161
14. Witte K.K.A., Cleland J.G.F., and Clark A.L. Chronotropic incompetence, chronic heart failure and beta-blockers. Heart 92 (2006) 481-486
15. Koelling T.M., Joseph S., and Aaronson K.D. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant 23 (2004) 1414-1422
16. Butler J., Khadim G., Paul K.M., et al. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol 43 (2004) 787-793
17. Geisberg C., Goring J., Listerman J., et al. Impact of optimal heart failure medical therapy on heart transplant listing. Transplant Proc 38 (2006) 1493-1495
18. Witte K.K.A., and Clark A.L. Is the elevated slope relating ventilation to carbon dioxide production in chronic heart failure a consequence of slow metabolic gas kinetics?. Eur J Heart Fail 4 (2002) 469-472
19. Buller N.P., and Poole-Wilson P.A. Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J 63 (1990) 281-283
20. Davies S.W., Emery T.M., Watling M.I.L., et al. A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure. Br Heart J 65 (1991) 179-183
21. 2 relationship during heavy, constant work rate exercise reflects the rate of lactic acid accumulation. Eur J Appl Physiol Occup Physiol 72 (1995) 25-31
22. 2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity. Am Heart J 145 (2003) 1102-1107
23. Clark A.L., Swan J.W., Laney R., et al. The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. Circulation 89 (1994) 2062-2069
24. Chandrashekhar Y., and Anand I.S. Relation between major indices of prognosis in patients with chronic congestive heart failure: studies of maximal exercise oxygen consumption, neurohormones and ventricular function. Indian Heart J 44 (1992) 213-216
25. Carell E.S., Murali S., Schulman D.S., et al. Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest 106 (1994) 1746-1752
26. Davies S.W., Fussell A.L., Jordan S.L., et al. Abnormal diastolic filling patterns in chronic heart failure-relationship to exercise capacity. Eur Heart J 13 (1992) 749-757
27. Higginbotham M.B., Morris K.G., Conn E.H., et al. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 51 (1983) 52-60
28. Benge W., Litchfield R.L., and Marcus M.L. Exercise capacity in patients with severe left ventricular dysfunction. Circulation 61 (1980) 955-959
29. Ribeiro J.P., White H.D., Arnold J.M., et al. Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure. Am J Med 81 (1986) 759-764
30. Petein M., Levine T.B., and Cohn J.N. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. Circulation 73 3 Pt 2 (1986) III230-III236
31. Leung T.C., Ballman K.V., Allison T.G., et al. Clinical predictors of exercise capacity 1 year after cardiac transplantation. J Heart Lung Transplant 22 (2003) 16-27
32. Douard H., Parrens E., Billes M.A., et al. Predictive factors of maximal aerobic capacity after cardiac transplantation. Eur Heart J 18 (1997) 1823-1828
33. Witte K.K.A., Thackray S.D.R., Nikitin N.P., et al. The effects of α- and β-blockade on ventilatory responses to exercise in chronic heart failure. Heart 89 (2003) 1169-1173
34. Marzo K., Herrmann H.A., Rein A., et al. Acute effect of balloon mitral valvuloplasty on exercise capacity ventilation and skeletal muscle oxygenation. Circulation 84 Suppl II (1991) 11-72
35. Smart N., Haluska B., Jeffriess L., et al. Cardiac contributions to exercise training responses in patients with chronic heart failure: a strain imaging study. Echocardiography 23 (2006) 376-382
36. Jonsdottir S., Andersen K.K., Sigurosson A.F., et al. The effect of physical training in chronic heart failure. Eur J Heart Fail 8 (2006) 97-101
37. Jondeau G., Katz S.D., Zohman L., et al. Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure. Circulation 86 (1992) 1351-1356
38. Williams S.G., Cooke G.A., Wright D.J., et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 22 (2001) 1496-1503
39. Samejima H., Omiya K., Uno M., et al. Relationship between impaired chronotropic response, cardiac output during exercise, and exercise tolerance in patients with chronic heart failure. Jpn Heart J 44 (2003) 515-525
40. Witte K.K.A., Nikitin N.P., Cleland J.G.F., et al. The effects of long-term β-blockade on the ventilatory responses to exercise in chronic heart failure. Eur J Heart Fail 4 (2005) 612-617
41. Meluzin J., Spinarova L., Hude P., et al. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J Am Soc Echocardiogr 18 (2005) 435-444
42. Szlachcic J., Massie B.M., Kramer B.L., et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 55 (1985) 1037-1042
43. Franciosa J.A., Baker B.J., and Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 110 (1985) 807-813
44. Metra M., Raddino R., Dei Cas L., et al. Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure. Am J Cardiol 65 (1990) 1127-1133
45. Gibbs J.S., Keegan J., Wright C., et al. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 15 (1990) 52-61
46. Moore D.P., Weston A.R., Hughes J.M.B., et al. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 339 (1992) 850-853
47. Wright R.S., Levine M.S., Bellamy P.E., et al. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest 98 (1990) 816-820
48. Clark A.L., Volterrani M., Swan J.W., et al. Increased ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology. Heart 77 (1997) 138-146
49. Kraemer M.D., Kubo S.H., Rector T.S., et al. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 21 (1993) 641-648
50. Ingle L., Shelton R.J., Cleland J.G., et al. Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failure. J Card Fail 11 (2005) 619-623
51. Witte K.K.A., Morice A., Clark A.L., et al. Airways resistance in chronic heart failure measured by impulse oscillometry. J Card Fail 8 (2002) 225-231
52. Witte K.K.A., Morice A., Clark A.L., et al. The reversibility of airways resistance in chronic heart failure. J Card Fail 10 (2004) 149-154
53. Light R.M., and George R.B. Serial pulmonary function in patients with acute heart failure. Arch Intern Med 143 (1983) 429-433
54. Peterman W., Barth J., and Entzian P. Heart failure and airways obstruction. Int J Cardiol 17 (1987) 207-209
55. Cabanes L.R., Weber S.N., Matran R., et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med 320 (1989) 1317-1322
56. Cabanes L., Costes F., Weber S., et al. Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function. N Engl J Med 326 (1992) 1661-1665
57. Chua T.P., Lalloo U.G., Worsdell M.Y., et al. Airway and cough responsiveness and exhaled nitric oxide in non-smoking patients with stable chronic heart failure. Heart 76 (1996) 144-149
58. Puri S., Baker B.L., Oakley C.M., et al. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J 72 (1994) 140-144
59. Puri S., Baker B.L., Dutka D.P., et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 91 (1995) 2769-2774
60. Smith A.A., Cowburn P.J., Parker M.E., et al. Impaired pulmonary diffusion during exercise in patients with chronic heart failure. Circulation 100 (1999) 1406-1410
61. Guazzi M., Pontone G., Brambilla R., et al. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 23 (2002) 467-476
62. Guazzi M., Marenzi G., Alimento M., et al. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 95 (1997) 1930-1936
63. Guazzi M., Reina G., Tumminello G., et al. Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure. J Appl Physiol 97 (2004) 1866-1873
64. Guazzi M., Tumminello G., Di Marco F., et al. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 44 (2004) 2339-2348
65. Agostoni P.G., Guazzi M., Bussotti M., et al. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 36 (2000) 1600-1604
66. Lindsay D.C., Lovegrove C.A., Dunn M.J., et al. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 17 (1996) 1239-1250
67. Carmo M.M., Barbara C., Ferreira T., et al. Diaphragmatic function in patients with chronic left ventricular failure. Pathophysiology 8 (2001) 55-60
68. Nava S., Larovere M.T., Fanfulla F., et al. Orthopnea and inspiratory effort in chronic heart failure patients. Respir Med 97 (2003) 647-653
69. Hughes P.D., Polkey M.I., Harrus M.L., et al. Diaphragm strength in chronic heart failure. Am J Respir Crit Care Med 160 (1999) 529-534
70. Dayer M.J., Hopkinson N.S., Ross E.T., et al. Does symptom-limited cycle exercise cause low frequency diaphragm fatigue in patients with heart failure?. Eur J Heart Fail 8 (2006) 68-73
71. Kufel T.J., Pineda L.A., Junega R.G., et al. Diaphragmatic function after intense exercise in congestive heart failure patients. Eur Respir J 20 (2002) 1399-1405
72. Clark A.L., Davies L.C., Francis D.P., et al. Ventilatory capacity and exercise tolerance in patients with chronic stable heart failure. Eur J Heart Fail 2 (2000) 47-51
73. St C., Croix M., Morgan B.J., et al. Reflex effects from a fatiguing diaphragm increase sympathetic efferent activity (MSNA) to limb muscle in humans. J Physiol 529 (2000) 493-504
74. Sheel A.W., Derchak P.A., Morgan B.J., et al. Fatiguing inspiratory muscle work causes reflex reduction in resting leg blood flow in humans. J Physiol 537 Pt 1 (2001) 277-289
75. Rubin S.A., Brown H.V., and Swan H.J.C. Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 66 (1982) 143-148
76. Clark A.L., and Coats A.J.S. Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure. Br Heart J 71 (1994) 528-530
77. Clark A.L., Poole-Wilson P.A., and Coats A.J.S. The relationship between ventilation and carbon dioxide production in patients with chronic heart failure. J Am Coll Cardiol 20 (1992) 1326-1332
78. 2 partial pressure. Eur Heart J 26 (2005) 472-480
79. Sullivan M.J., Higginbotham M.B., and Cobb F.R. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 77 (1988) 552-559
80. Rubin S.A., and Brown H.V. Ventilation and gas exchange during exercise in severe chronic heart failure. Am Rev Respir Dis 129 2 Pt 2 (1984) S63-S64
81. Weber K.T., Kinasewitz G.T., Janicki J.S., et al. Oxygen utilisation and ventilation during exercise in patients with chronic cardiac failure. Circulation 65 (1982) 1213-1223
82. Witte K.K., Thackray S.D., Nikitin N.P., et al. Pattern of ventilation during exercise in chronic heart failure. Heart 89 (2003) 610-614
83. Lewis N.P., Banning A.P., Cooper J.P., et al. Impaired matching of perfusion and ventilation in heart failure detected by 133xenon. Basic Res Cardiol 91 Suppl 1 (1996) 45-49
84. Wada O., Asanoi H., Miyagi K., et al. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure. Am Heart J 125 (1993) 790-798
85. Uren N.G., Davies S.W., Agnew J.E., et al. Reduction of mismatch of global ventilation and perfusion on exercise is related to exercise capacity in chronic heart failure. Br Heart J 70 (1993) 241-246
86. Metra M., Dei Cas L., Panina G., et al. Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol 70 (1992) 622-628
87. Clark A.L., and Coats A.J. Relationship between ventilation and carbon dioxide production in normal subjects with induced changes in anatomical dead space. Eur J Clin Invest 23 (1993) 428-432
88. Mohsenifar Z., Amin D.K., and Shah P.K. Regional distribution of lung perfusion and ventilation in patients with chronic congestive heart failure and its relationship to cardiopulmonary hemodynamics. Am Heart J 117 (1989) 887-891
89. Agostoni P., Contini M., Magini A., et al. Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. Eur J Heart Fail 8 (2006) 729-735
90. Clark A.L., Volterrani M., Piepoli M., et al. Factors which alter the relationship between ventilation and carbon dioxide production during exercise: implications for the understanding of the increased ventilatory response to exercise in chronic heart failure. Eur J Appl Physiol 73 (1996) 144-148
91. Wasserman K., Whipp B.J., Koyal S.N., et al. Effect of carotid body resection on ventilatory and acid-base control during exercise. J Appl Physiol 39 (1975) 354-358
92. Lugliani R., Whipp B.J., Seard C., et al. Effects of bilateral carotid body resection on ventilatory control at rest and during exercise in man. N Engl J Med 285 (1971) 1105-1111
93. Whipp B.J., and Wasserman K. Carotid bodies and ventilatory control dynamics in man. Fed Proc 39 (1980) 1628-1673
94. Koslowski S., Rasmussen B., and Wilkoff W.G. The effect of high oxygen tensions on ventilation during severe exercise. Acta Physiol Scand 81 (1971) 385-395
95. Oren A., Whipp B.J., and Wasserman K. The effects of acid-base status on the kinetics of ventilatory response to moderate exercise. J Appl Physiol 52 (1982) 1013-1017
96. Brice A.G., Forster H.V., Pan J.G., et al. Is the hyperpnoea of muscular contractions critically dependant on spinal afferents?. J Appl Physiol 64 (1988) 226-233
97. Whipp B.J., Wasserman K., Casaburi R., et al. Ventilatory control characteristics of conditions resulting in isocapnic hyperpnoea. In: Lahiri R., and Gautier S. (Eds). Control of respiration during sleep and anaesthesia (1978), Plenum Press, New York 355-365
98. Whipp B.J., Davis J.A., and Wasserman K. Ventilatory control of the 'isocapnic buffering' region in rapidly incremental exercise. Respir Physiol 76 (1989) 357-368
99. Torre-Bueno J., Wagner P.D., Saltzman H.A., et al. Diffusion limitation in normal humans during exercise at sea level and simulated altitude. J Appl Physiol 58 (1985) 989-995
100. Wagner P.D., Sutton J.R., Reeves J.T., et al. Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt Everest. J Appl Physiol 63 (1988) 2348-2359
101. Heigenhauser G.J.F., Sutton J.R., and Jones N.L. Effect of glycogen depletion on the ventilatory response to exercise. J Appl Physiol 54 (1983) 470-474
102. Hughes E.F., Turner S.C., and Brooks G.A. Effects of glycogen depletion and pedalling speed on 'anaerobic threshold'. J Appl Physiol 52 (1982) 1598-1607
103. 2 relationship. J Appl Physiol 62 (1987) 1460-1464
104. Clark A.L., Piepoli M., and Coats A.J. Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors. Eur J Clin Invest 25 (1995) 299-305
105. 2 as a clinical test of the peripheral chemoreflex. J Appl Physiol 64 (1988) 84-89
106. Read D.J.C. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 16 (1966) 20-32
107. Chua T.P., Clark A.L., Amadi A., et al. Relationship between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 27 (1996) 650-657
108. Chua T.P., Ponikowski P.P., Harrington D., et al. Contribution of peripheral chemoreceptors to ventilation and the effects of their suppression on exercise tolerance in chronic heart failure. Heart 76 (1996) 483-489
109. Sun S.-Y., Wang W., Zucker I.H., et al. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86 (1999) 1273-1282
110. Sun S.-Y., Wang W., Zucker I.H., et al. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86 (1999) 1264-1272
111. Sullivan M.J., Knight J.D., Higginbotham M.B., et al. Relation between central and peripheral haemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 80 (1989) 769-781
112. LeJemtel T.H., Maskin C.S., Lucido D., et al. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 74 (1986) 245-251
113. LeJemtal T.H., Maskin C.S., Chadwick B., et al. Near maximal oxygen extraction by exercising muscles in patients with severe heart failure: a limitation to the benefits of training. J Am Coll Cardiol 1 (1983) 662
114. Wroblewski H., Kastrup J., Norgaard T., et al. Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 69 (1992) 769-774
115. Arnold J.M.O., Marchiori G.E., Imrie J.R., et al. Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and haemodynamics. Circulation 84 (1991) 2418-2425
116. Zelis R., Nellis S.H., Longhurst J., et al. Abnormalities in the regional circulations accompanying congestive heart failure. Prog Cardiovasc Dis 18 (1975) 181-199
117. Kubo S.H., Rector T.S., Bank A.J., et al. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84 (1991) 1589-1596
118. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19 (1992) 918-925
119. Bank A.J., Rector T.S., Burke M.N., et al. Impaired forearm vasodilation to hyperosmolal stimuli in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 70 (1992) 1315-1319
120. Franciosa J.A., Goldsmith S.R., and Cohn J.N. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med 69 (1980) 559-566
121. McMurray J.J., Ray S.G., Abdullah I., et al. Plasma endothelin in chronic heart failure. Circulation 85 (1992) 1374-1379
122. Witte K.K.A., de Silva R., Chattopadhahy S., et al. Are haematinic deficiencies the cause of anaemia in chronic heart failure?. Am Heart J 147 (2004) 924-930
123. de Silva R., Rigby A.S., Witte K.K., et al. Anemia, renal dysfunction and their interaction in patients with chronic heart failure. Am J Cardiol 98 (2006) 391-398
124. Mancini D.M., Katz S.D., Lang C.C., et al. Effect of erythropoietin on exercise capacity on patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
125. Lipkin D.P., Jones D.A., Round J.M., et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 18 (1988) 187-195
126. Volterrani M., Clark A.L., Ludman P.F., et al. Determinants of exercise capacity in chronic heart failure. Eur Heart J 15 (1994) 801-809
127. Clark A., and Coats A. Mechanisms of exercise intolerance in cardiac failure: abnormalities of skeletal muscle and pulmonary function. Curr Opin Cardiol 9 (1994) 305-314
128. Minotti J.R., Pillay P., Oka R., et al. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 75 (1993) 373-381
129. Mancini D.M., Walter G., Reichnek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85 (1992) 1364-1373
130. Buller N.P., Jones D., and Poole-Wilson P.A. Direct measurements of skeletal muscle fatigue in patients with chronic heart failure. Br Heart J 65 (1991) 20-24
131. Minotti J.R., Pillay P., Chang L., et al. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation 86 (1992) 903-908
132. Wilson J.R., Mancini D.M., and Simson M. Detection of skeletal muscle fatigue in patients with heart failure using electromyography. Am J Cardiol 70 (1992) 488-493
133. Minotti J.R., Christoph I., Oka R., et al. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest 88 (1991) 2077-2082
134. McLoughlin P., Popham P., Bruce R.C.H., et al. Plasma potassium and the ventilatory threshold in man. J Physiol 427 (1990) 44
135. Scott A.C., Wensel R., Davos C.H., et al. Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control. Circulation 106 (2002) 214-220
136. Paterson D.J., Robbins P.A., and Conway J. Changes in arterial plasma potassium and ventilation during exercise in man. Respir Physiol 78 (1989) 323-330
137. Schaufelberger M., Eriksson B.O., Grimby G., et al. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J 18 (1997) 971-980
138. Sullivan M.J., Green H.J., and Cobb F.R. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81 (1990) 518-527
139. 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 80 (1989) 1338-1346
140. Schaufelberger M., Eriksson B.O., Held P., et al. Skeletal muscle metabolism during exercise in patients with chronic heart failure. Heart 76 (1996) 29-34
141. Sullivan M.J., Green H.J., and Cobb F.R. Altered skeletal muscle response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 84 (1991) 1597-1607
142. Drexler H., Funke E., and Riede U. The oxidative enzyme activity decreases in all fibre types in skeletal muscle of patients with chronic heart failure. Circulation 84 Suppl II (1991) II-74
143. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 60 (1987) 309-315
144. Massie B.M., Conway M., Yonge R., et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 76 (1987) 1009-1019
145. Mancini D.M., Henson D., LaManca J., et al. Respiratory muscle function and dyspnoea in patients with chronic congestive heart failure. Circulation 86 (1992) 909-919
146. Wiener D.H., Fink L.I., Maris J., et al. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: relation to clinical severity and blood flow. Circulation 73 (1986) 1127-1136
147. Massie B.M., Conway M., Rajagopalan B., et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 78 (1988) 320-326
148. Wallimann T., Wyss M., Brdiczka D., et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 281 Pt 1 (1992) 21-40
149. Vescovo G., Serafini F., Facchin L., et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 76 (1996) 337-343
150. Wilson J.R., Martin J.L., Schwartz D., et al. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 69 (1984) 1079-1087
151. Drexler H., Banhardt U., Meinertz T., et al. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 79 (1989) 491-502
152. Herrlin B., and Sylvén C. Increased arterial oxygen content-an important compensatory mechanism in chronic moderate heart failure. Cardiovasc Res 25 (1991) 384-390
153. Bannister R.G., and Cunningham D.J.C. The effects on the respiration and performance during exercise of adding oxygen to the inspired air. J Physiol 125 (1954) 1118-1137
154. Wilson J.R., Martin J.L., and Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 53 (1984) 1308-1315
155. Anker S.D., Swan J.W., Volterrani M., et al. The influence of muscle mass, strength, fatigability, and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 18 (1997) 259-269
156. Wilson J.R., Mancini D.M., and Dunkman W.B. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 87 (1993) 470-475
157. Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 30 (1997) 527-532
158. Doehner W., Rauchhaus M., Ponikowski P., et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46 (2005) 1019-1026
159. Niebauer J., Pflaum C.D., Clark A.L., et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 32 (1998) 393-397
160. 31P nuclear magnetic resonance spectroscopy study of leg muscle. Clin Sci 79 (1990) 583-589
161. Piepoli M., Clark A.L., and Coats A.J.S. Muscle metaboreceptors in the hemodynamic, autonomic and ventilatory responses to exercise in man. Am J Physiol 269 (1995) H1428-H1436 [Heart Circ Physiol 38]
162. Piepoli M., Clark A.L., Volterrani M., et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 93 (1996) 940-952
163. Grieve D.A.A., Clark A.L., McCann G.P., et al. The ergoreflex in patients with chronic stable heart failure. Int J Cardiol 68 (1999) 157-164
164. Scott A.C., Francis D.P., Davies L.C., et al. Contribution of skeletal muscle 'ergoreceptors' in the human leg to respiratory control in chronic heart failure. J Physiol 529 Pt 3 (2000) 863-870
165. Sjoggard G., Adams R.A., and Saltin B. Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol 248 (1985) R190-R196
166. Linton R.A.F., and Band D.M. The effects of potassium on carotid body chemoreceptor activity and ventilation in the cat. Respir Physiol 59 (1985) 65-70
167. Lim M., Linton R.A.F., Wolff C.B., et al. Propranolol, exercise and arterial potassium. Lancet ii (1981) 591
168. Witte K.K., and Clark A.L. The effect of aspirin on the ventilatory response to exercise in chronic heart failure. Eur J Heart Fail 6 (2004) 745-748
169. Middlekauff H.R., Chiu J., Hamilton M.A., et al. Muscle mechanoreceptor sensitivity in heart failure. Am J Physiol Heart Circ Physiol 287 (2004) H1937-H1943
170. Negrão C.E., Rondon M.U., Tinucci T., et al. Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart Circ Physiol 280 (2001) H1286-H1292
171. Clark A.L., Poole-Wilson P.A., and Coats A.J. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28 (1996) 1092-1102
172. Kaye D.M., Lambert G.W., Lefkovits J., et al. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 23 (1994) 570-578
173. Hasking G.J., Esler M.D., Jennings G.L., et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73 (1986) 615-621
174. Notarius C.F., Ando S., Rongen G.A., et al. Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects. Eur Heart J 20 (1999) 880-887
175. Francis G.S., Cohn J.N., Johnson G., et al. Plasma norephinephrine, plasma rennin activity and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II follow-up. Circulation 87 Suppl VI (1993) 40-48
176. Notarius C.F., Atchison D.J., and Floras J.S. Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. Am J Physiol Heart Circ Physiol 280 (2001) H969-H976
177. Bayliss J., Norell M., Canepa-Anson R., et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57 (1987) 17-22
178. Clark A.L., and Cleland J.G. The control of adrenergic function in heart failure: therapeutic intervention. Heart Fail Rev 5 (2000) 101-114
179. Ellenbogen K.A., Mohanty P.K., Szentpetery S., et al. Arterial baroreflex abnormalities in heart failure: reversal after orthotopic cardiac transplantation. Circulation 79 (1989) 51-58
180. Marin-Neto J.A., Pintya A.O., Gallo Jr. L., et al. Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation. Am J Cardiol 67 (1991) 604-610
181. Grassi C., Seravalle G., Cattaneo B.M., et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92 (1995) 3206-3211
182. Ferguson D.W., Abboud F.M., and Mark A.L. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation 69 (1984) 451-460
183. Heistad D.D., Abboud F.M., Mark A.L., et al. Interaction of baroreceptor and chemoreceptor reflexes: modulation of the chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest 53 (1974) 1226-1236
184. Somers V.K., Mark A.L., and Abboud F.M. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 87 (1991) 1953-1957
185. Ponikowski P., Chua T.P., Piepoli M., et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96 (1997) 2586-2594
186. Narkiewicz K., Pesek C.A., van de Borne P.J.H., et al. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100 (1999) 262-267
187. van de Borne P., Oren R., Anderson E.A., et al. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation 94 (1996) 1325-1328
188. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 349 (1997) 375-380
189. US Carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 94 (1996) 2800-2806
190. Cohn J.N., Fowler M.B., Bristow M.R., et al., for the US Carvedilol Heart failure Study Group. Safety and efficacy of carvedilol in severe heart failure. J Card Fail 3 (1997) 173-179
191. Clark A.L., Galloway S., MacFarlane N., et al. Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans. Eur Heart J 18 (1997) 1829-1833
192. van Tol B.A., Huijsmans R.J., Kroon D.W., et al. Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis. Eur J Heart Fail (2006) [Electronic publication ahead of print]
193. Passino C., Severino S., Poletti R., et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 47 (2006) 1835-1839
194. Roveda F., Middlekauff H.R., Rondon M.U., et al. The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42 (2003) 854-860
195. Hambrecht R., Fiehn E., Yu J., et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 29 (1997) 1067-1073
196. Hambrecht R., Niebauer J., Fiehn E., et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 25 (1995) 1239-1249
197. Kobayashi N., Tsuruya Y., Iwasawa T., et al. Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained extremities. Circ J 67 (2003) 505-510
198. Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98 (1998) 2709-2715
199. Linke A., Schoene N., Gielen S., et al. Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol 37 (2001) 392-397
200. Miche E., Herrmann G., and Nowak M. Effect of an exercise training program on endothelial dysfunction in diabetic and non-diabetic patients with severe chronic heart failure. Clin Res Cardiol 95 Suppl 1 (2006) i117-i124